SEIZE THE $50 BILLION SITE-OF-CARE SHIFT OPPORTUNITY
Get the tools, data, and insights to drive growth.
Learn more

 We are pausing publication of The Daily Briefing out of respect for the tragic passing of Brian Thompson. We will resume publication of this daily newsletter in the coming days.

Expert Insight

Generative AI in healthcare: Q&A with IMO Health CTO Chuck Levecke

Dive into the emerging landscape of generative AI in healthcare with IMO Health CTO Chuck Levecke as he discusses its transformative potential and addresses industry skepticism. Learn about AI applications in ambient computing and data analysis, and discover why healthcare leaders are exploring generative AI as a strategic investment in a market projected to surpass $21 billion by 2032.

With the widespread usage of tools like ChatGPT and Copilot, it’s clear that generative AI is here to stay – and the healthcare sector is experimenting with its potential. Generative AI is a type of artificial intelligence capable of creating new, unique content by learning from data.

According to Deloitte Center for Health Solutions, 75% of leading healthcare companies are experimenting with or planning to scale generative AI across their enterprise. Generative AI’s popularity and financial investments are only expected to grow. In fact, by 2032, the global generative AI in healthcare market size is projected to surpass $21 billion.

We spoke with IMO Health’s CTO Chuck Levecke about the opportunities for generative AI in healthcare. With over two decades of experience in healthcare tech, Levecke shares his thoughts on the emerging capabilities of ambient AI and how healthcare leaders can develop a comprehensive AI strategy to drive value and leverage efficiency.

What are the top applications of generative AI right now in healthcare?

Generative AI is making a significant impact in the healthcare sector by providing tools that assist in managing and interpreting large datasets. In an emergency room, where timely decisions are crucial, a patient's complex medical history can be a challenge to navigate quickly.

Generative AI can process this information rapidly, identifying and prioritizing the most vital parts of the patient's history. This could lead to more streamlined patient care and an increase in operational efficiency within these high-pressure environments.

Utilizing these AI systems goes beyond the basic summarization of data, too. They are becoming more adept at extracting specific, clinically relevant information from the extensive and often unstructured text within medical records.

What opportunities does generative AI offer for provider organizations like hospitals and health systems?

One major opportunity is the transition from structured data entry to ambient computing. Ambient computing involves the use of AI to listen to and analyze conversations between patients and physicians, with the goal of generating electronic health record (EHR) data directly from these interactions.

Existing products that have traditionally relied on manual point-and-click interfaces for data entry are now incorporating AI to enhance their functionality. This shift is driven by the need to address physician burnout and staff shortages.

By automating data capture, generative AI can alleviate some of the administrative burdens on clinical staff, allowing them to focus more on patient care.

What opportunities does generative AI provide for healthcare industry companies like life sciences and tech?

At IMO Health, we’re actively seeking to enhance the integration of healthcare provider data with payer systems, specifically targeting the life sciences sector. Our approach includes mining data for clinically relevant information, while ensuring compliance through diligent internal review processes.

In working with several pharmaceutical companies, we leverage our comprehensive terminology to identify patterns in their searches for rare diseases. By doing so, we can align these findings with clinical trials that are actively seeking participants who have specific, often hard-to-identify conditions.

AI allows us to streamline this intricate process and to serve as a matchmaker between doctors with appropriate patient cases and pharmaceutical companies developing promising therapeutics.

What resistance or skepticism have you encountered from the healthcare industry regarding the adoption of generative AI?

When it comes to using AI in healthcare, there are concerns about legal issues, security, and data rights. Some healthcare companies are wary and aren't even willing to start discussions about the legal implications of AI. At IMO Health, we've made progress by working closely with our security and legal teams to navigate these uncertainties.

Another point of skepticism is the belief that AI is a one-size-fits-all solution. That’s not always the case. We prefer a balanced approach at IMO Health, using different methods like traditional machine learning or even simple data matching before moving on to more complex AI. It's about choosing the right tool for the problem, and often, combining AI with other techniques is the most effective strategy. This not only solves problems more efficiently but also helps manage costs and improve performance.

From your perspective, what advancements in generative AI are currently having the most impact?

I'm really excited about the potential of ambient technology in healthcare. I have many physician friends who are eager for solutions that allow them to focus more on patient care rather than on administrative tasks like data entry. Ambient technology has the real potential to transform the day-to-day of healthcare professionals. Additionally, there’s a lot of excitement around automation in more traditional areas, like updating customer dictionaries and regulatory code sets. These are tasks that can be effectively streamlined with new AI tech tools.

What should healthcare leaders consider when investing their time and money in AI with a goal of creating operating leverage and driving value?

First, leaders must first gain a clear understanding of how AI could potentially disrupt their current services. This involves bringing in external experts who can offer an objective perspective on the future landscape of healthcare technology. Next, it's important to evaluate the existing portfolio of services and products to pinpoint where AI can add value. This may mean integrating AI to streamline processes, enhance decision-making, or improve patient interactions.

Furthermore, leaders should develop a clear strategy for employing AI to increase operational efficiency. Improvements in efficiency support cost savings and additional resources to be reinvested in areas of growth and innovation. Finally, leadership in AI requires having the right experts on board. Healthcare organizations should actively seek and attract thought leaders and skilled professionals in AI who can craft strategies that are both progressive and in step with the latest developments in AI.


About the sponsor

Intelligent Medical Objects is a healthcare data enablement company that ensures clinical data integrity and quality — making patient information fit-for-purpose across the healthcare ecosystem, from hospitals to health information exchanges to payers, and beyond.

IMO’s vast footprint in EHRs powers our ability to capture and preserve clinical intent at the highest level of specificity. Our secure technology platform and products then help our clients to transform and extract the greatest value from their data.

In short, IMO is the catalyst that enables accurate documentation, precise population cohorting, optimized reimbursements, robust analytics, and better care decisions to optimize patient outcomes.

For more information about IMO, visit https://imohealth.com.

This article is sponsored by IMO Health, an Advisory Board member organization. Representatives of IMO helped select the topics and issues addressed. Advisory Board experts maintained final editorial approval, and conducted the underlying research independently and objectively. Advisory Board does not endorse any company, organization, product or brand mentioned herein.

View Advisory Board's editorial guidelines.


Sponsored by

This article is sponsored by IMO Health. An Advisory Board expert conducted the interview, wrote the article and maintained final editorial approval.

Learn more about IMO Health


SPONSORED BY

INTENDED AUDIENCE
  • Digital health
  • Hospitals and health systems

AFTER YOU READ THIS
  • You'll learn about the opportunities for generative AI in healthcare.
  • You'll learn how to develop a comprehensive AI strategy to drive value and leverage efficiency.

AUTHORS

Emily Schmidt

Senior writer and editor, Sponsorship

TOPICS

INDUSTRY SECTORS

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.